58
Participants
Start Date
December 14, 2021
Primary Completion Date
August 12, 2022
Study Completion Date
September 11, 2022
remimazolam-based TIVA
In the remimazolam-based TIVA group, general anesthesia is induced and maintained with a continuous infusion of remimazolam using an infusion pump. In the remimazolam group, its antagonist, flumazenil, is administered at the end of surgery.
propofol-based TIVA
In the propofol-based TIVA group, general anesthesia is induced and maintained with a target-controlled infusion of propofol using an infusion pump (Orchestra®; Fresenius Vial, France).
Seoul National University Hospital, Seoul
Hana Pharm Co., Ltd.
INDUSTRY
Seoul National University Hospital
OTHER